Tuberculosis (TB) Diagnostics Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The Global Tuberculosis (TB) Diagnostics Market is expected to witness a CAGR of 4% over the forecast period 2022-2028. 

Tuberculosis (TB) is caused by a bacterium called Mycobacterium tuberculosis. Bacteria usually attack the lungs, but TB bacteria can attack any part of the body, such as the kidneys, spine, and brain. Not all people infected with Mycobacterium tuberculosis become ill. As a result, two TB-related conditions exist: latent TB infection (LTBI) and TB disease.

Market Segments

By Disease Stage

• Latent Tuberculosis
• Active Tuberculosis

By Test Type

• Radiographic Method
• Cytokine Detection Assay
• Nucleic Acid Testing
• Detection of Latent Infection
• Diagnostic Laboratory Method
• Detection of Drug Resistance
• Others

Key Players

Key participants include Alere Inc., F.Hoffmann-La Roche AG, Abbott Laboratories, Becton, Dickinson and Company, bioMérieux SA, Siemens, Hologic Corporation, Cepheid, Hain Lifesciences GmbH, and Thermo Fisher Scientific Inc.

Scope of the Report

The research study analyzes the global Tuberculosis (TB) Diagnostics industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Tuberculosis (TB) Diagnostics Market Report

1. What was the Tuberculosis (TB) Diagnostics Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2022-2028).

2. What will be the CAGR of Tuberculosis (TB) Diagnostics Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Tuberculosis (TB) Diagnostics Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.